Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management

In patients with active cancer and atrial fibrillation (AF) anticoagulation, thrombotic and bleeding risk still entail uncertainty.We explored the results of an international survey examining the knowledge and behaviours of a large group of physicians.A web-based survey was completed by 960 physicians (82.4% cardiologists, 75.5% from Europe). Among the currently available anticoagulants for stroke prevention in patients with active cancer,...